VETERINARY DEXTROSE- dextrose monohydrate injection, solution

Valsts: Amerikas Savienotās Valstis

Valoda: angļu

Klimata pārmaiņas: NLM (National Library of Medicine)

Aktīvā sastāvdaļa:

DEXTROSE MONOHYDRATE (UNII: LX22YL083G) (ANHYDROUS DEXTROSE - UNII:5SL0G7R0OK)

Pieejams no:

Zoetis Inc.

Ievadīšanas:

INTRAVENOUS

Receptes veids:

PRESCRIPTION

Ārstēšanas norādes:

5% Dextrose Injection, USP is indicated as a source of water and calories. Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.

Produktu pārskats:

5% Dextrose Injection, USP in plastic container is available as follows:     Size (mL)     Code                 1000             2B8264          Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C/77°F); brief exposure up to 40°C/104°F does not adversely affect the product.

Autorizācija statuss:

unapproved drug other

Produkta apraksts

VETERINARY DEXTROSE- DEXTROSE MONOHYDRATE INJECTION, SOLUTION
ZOETIS INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
VETERINARY 5% DEXTROSE INJECTION, USP
For Animal Use Only
DES CRIPTION
5% Dextrose Injection, USP is a sterile, nonpyrogenic solution for
fluid replenishment and caloric
supply in single dose containers for intravenous administration. It
contains no antimicrobial agents.
Discard unused portion. Composition, osmolarity, pH, and caloric
content are shown in table 1.
The plastic container is fabricated from a specially formulated
polyvinyl chloride. The amount of water
that can permeate from inside the container into the overwrap is
insufficient to affect the solution
significantly. Solutions in contact with the plastic container can
leach out certain of its chemical
components in very small amounts within the expiration period, e.g.,
di-2-ethylhexyl phthalate (DEHP),
up to 5 parts per million. However, the safety of the plastic has been
confirmed in tests in animals
according to USP biological test for plastic containers as well as by
tissue culture toxicity studies.
CLINICAL PHARMACOLOGY
5% Dextrose Injection, USP has value as a source of water and
calories.
It is capable of inducing diuresis depending on the clinical condition
of the patient.
INDICATIONS AND USAGE
5% Dextrose Injection, USP is indicated as a source of water and
calories.
CONTRAINDICATIONS
Solutions containing dextrose may be contraindicated in patients with
known allergy to corn or corn
products.
WARNINGS
5% Dextrose Injection, USP should not be administered simultaneously
with blood through the same
administration set because of the possibility of pseudoagglutination
or hemolysis.
The intravenous administration of 5% Dextrose Injection, USP can cause
fluid and/or solute
overloading resulting in dilution of serum electrolyte concentrations,
overhydration, congested states,
or pulm